Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Premier Health of America Inc V.PHA

Premier Health of America Inc. is a Canada-based healthtech company. The Company is a specialized healthcare services company that provides a range of staffing and outsourced service solutions for healthcare needs to governments, corporations, and individuals. The Company operates through two segments: Per Diem and Travel Nurse. The Company’s Per diem segment includes staff who work on an as-needed basis, sometimes for multiple health care institutions and are typically assigned shifts at the last minute and paid directly tied to worked hours. Its Travel Nurse segment includes healthcare professionals who work in temporary positions, carrying out short- and medium-term assignments that require travel, especially in remote areas. Its services are provided through its LiPHe platform developed with the objective of optimizing and streamlining the business-to-customer relationship and product offering through the use of business process automation and business intelligence applications.


TSXV:PHA - Post by User

Post by colouramaon Feb 17, 2023 11:49am
171 Views
Post# 35292197

Q1 2023 estimates

Q1 2023 estimatesAside from everyone writing off the company as now being worth 0 cents, what do we expect for Q1 2023?

The fact that they have already bought back 65% (nearly 1 million) of the maximum shares permitted of the NCIB in 3 months, suggests there was a strong demand up again last Sept-Dec.

I am hoping for $23 million in revenue, and $2.3 million EBITDA with a 10% margin.
<< Previous
Bullboard Posts
Next >>